2025-05-12T15:05:03-05:00 2024-06-30 911194016 CLARK NUBER PS 10900 NE 4TH ST STE 1400 BELLEVUE WA 98004 990 2023-07-01 832302258 WASHINGTON INSTITUTE FOR COAGULATION WASH 2066141200 701 PIKE STREET 1900 SEATTLE WA 98101 EVA SZYSZKA CFO/COO 2066141200 2025-05-06 1 0 MEGAN R RYAN P00737884 4254544919 2025-05-06 2023 2025-03-06 01:10:19Z WASHINGTON CENTER FOR BLEEDING DISORDERS EVA SZYSZKA 701 PIKE STREET 1900 SEATTLE WA 98101 122490634 0 X WWW.WACBD.ORG X 2018 WA THE WASHINGTON CENTER FOR BLEEDING DISORDERS (WACBD) IS DEDICATED TO SECURE, PROMOTE AND PROTECT OPTIMAL HEALTH FOR PEOPLE WITH BLEEDING DISORDERS THROUGH COMPREHENSIVE CARE, EDUCATION AND RESEARCH IN PARTNERSHIP WITH OUR PATIENTS, THEIR FAMILIES, AND THE LOCAL AND NATIONAL BLEEDING DISORDERS COMMUNITY. 5 4 43 4 0 0 64246 86695 113813074 120300458 603965 2094595 0 8886 114481285 122490634 0 0 0 0 5913095 8016808 0 0 0 98452689 100881559 104365784 108898367 10115501 13592267 74267913 78674468 33833067 24646432 40434846 54028036 X THE WASHINGTON CENTER FOR BLEEDING DISORDERS (WACBD) IS DEDICATED TO SECURE, PROMOTE AND PROTECT OPTIMAL HEALTH FOR PEOPLE WITH BLEEDING DISORDERS THROUGH COMPREHENSIVE CARE, EDUCATION AND RESEARCH IN PARTNERSHIP WITH OUR PATIENTS, THEIR FAMILIES, AND THE LOCAL AND NATIONAL BLEEDING DISORDERS COMMUNITY. 0 0 6930467 569391 CLINICAL SERVICES: AS A RECOGNIZED HEMOPHILIA TREATMENT CENTER AND A CENTER OF EXCELLENCE, WE ARE COMMITTED TO THE WELLBEING OF PATIENTS WITH AN INHERITED BLEEDING DISORDER ACROSS THE STATE OF WASHINGTON, NEIGHBORING STATES, AND ALASKA. WE ARE DEDICATED TO REFINED DIAGNOSISAND ASSESSMENT, SECURE ACCESS TO THERAPIES AND COMPREHENSIVE TREATMENT PLANNING AND READILY AVAILABLE CONSULTATION. WE STRIVE TO FOSTER OUR PATIENTS' AUTONOMY TO SAFELY CARE FOR THEIR DISORDER AND CAUSE MINIMAL DISRUPTION TO THEIR LIVES. A MULTIDISCIPLINARY TEAM OF HEALTH-CARE PROFESSIONALS ADDRESSES CONCERNS INCLUDING DIAGNOSIS, TREATMENT, EDUCATION, HEALTH INSURANCE, ORTHOPEDICS, AND DENTISTRY. EXPERT PEDIATRIC SERVICES ARE COORDINATED WITH SPECIALISTS AT SEATTLE CHILDREN'S HOSPITAL IN SEATTLE, PROVIDENCE SACRED HEART MEDICAL CENTER AND CHILDREN'S HOSPITAL IN SPOKANE, AND MARY BRIDGE MEDICAL CENTER AND CHILDREN'S HOSPITAL IN TACOMA. OUTREACH CLINICS ARE CONDUCTED IN TRI-CITIES, YAKIMA, SPOKANE, WENATCHEE, OLYMPIA, AND SEDRO-WOOLLEY. HOME VISITS TO FAMILIES AND IN-SERVICE MEETINGS WITH HEALTH-CARE PROFESSIONALS ARE PROVIDED THROUGHOUT THE STATE OF WASHINGTON. PROGRAM STAFF ALSO COORDINATE COMMUNITY RESOURCES FOR HEMOPHILIA CARE, EMERGENCY ROOM TREATMENT, INVASIVE PROCEDURES, AND OTHER MEDICAL SPECIALTY CLINICS. 99479329 119731067 PHARMACY SERVICES: AS AN INTEGRAL PART OF OUR COMPREHENSIVE CARE MODEL, OUR PHARMACY PROVIDES BLOOD CLOTTING FACTOR PRODUCTS TO PATIENTS AND HOSPITAL PROVIDERS THROUGHOUT THE STATE OF WASHINGTONAND PARTS OF ALASKA, MONTANA, AND IDAHO. PHARMACY SERVICES AT THE WASHINGTON CENTER FOR BLEEDING DISORDERS (WACBD) HAS TWO PRIMARY COMPONENTS, A LICENSED HEMOPHILIA SPECIALTY PHARMACY, AND A LICENSED PHARMACEUTICAL WHOLESALER. THE HEMOPHILIA SPECIALTY PHARMACY SUPPORTS CLINICAL OPERATIONS FOR MORE THAN 550 ADULT PATIENTS WHO RECEIVE CARE AT OUR MAIN FACILITY IN SEATTLE, WA AND AT OUTREACH CLINICS THROUGHOUT THE STATE OF WASHINGTON. THE PHARMACY ALSO PROVIDES SUPPORT TO THE MORE THAN 450 CHILDREN WITH BLEEDING DISORDERS WHO RECEIVE CARE AT OUR AFFILIATED CHILDREN'S CENTERS LOCATED IN TACOMA, SEATTLE, AND SPOKANE, WASHINGTON. PATIENT SERVICES ARE PROVIDED PRIMARILY THROUGH THE FILLING OF MAIL ORDER PRESCRIPTIONS AND PATIENT COUNSELING ON FACTOR AND NON-FACTOR PRESCRIPTION MEDICATIONS FOR TREATMENT OF VARIETY OF BLEEDING DISORDERS. THE WHOLESALE OPERATIONS PROVIDE 24 HOUR A DAY/7 DAY A WEEK SUPPORT TO WACBD CLINICAL CONSULTANTS AND OVER 70 HOSPITALS IN WASHINGTON STATE, WHO REQUIRE BLOOD FACTOR REPLACEMENT PRODUCTS AND SPECIALTY PHARMACEUTICALS FOR TREATMENT OF PATIENTS WITH BLEEDING DISORDERS. 106409796 1 1 0 0 0 0 0 0 0 0 1 0 0 1 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 12 0 43 1 0 0 0 0 0 0 0 0 0 0 0 0 X 5 4 0 0 1 0 0 0 0 1 1 0 0 1 1 1 1 1 0 0 1 0 X EVA SZYSZKA 2063374246 701 PIKE STREET SUITE 1900 SEATTLE WA 98101 REBECCA KRUSE-JARRES MD EXECUTIVE/MEDICAL DIRECTOR 40.00 0.00 X X 284614 0 66345 KRISTIAN PRILL HAMILTON PRESIDENT 1.00 0.00 X X 0 0 0 NEIL JOSEPHSON MD VICE PRESIDENT 1.00 0.00 X X 0 0 0 KRISHNA JAFA TREASURER 1.00 0.00 X X 0 0 0 ROSHNI KULKARNI BOARD DIRECTOR 1.00 0.00 X 0 0 0 KIM R SNYDER CHIEF FINANCIAL OFFICER/COO 40.00 0.00 X 245217 0 13099 HSIN KAI A CHEN PHARMACY DIRECTOR 40.00 0.00 X 164615 0 23245 HEEBEEN KIM CLINICAL PHARMACIST 40.00 0.00 X 145592 0 25060 CATLIN T GOODFRIEND CLINICAL PHARMACIST 40.00 0.00 X 134579 0 23894 KHOA C LE CLINICAL PHARMACIST 40.00 0.00 X 134401 0 10587 RENEE M KILLIAN CLINCIAL NURSE COORDINATOR 40.00 0.00 X 128294 0 23404 ANNE JEZZAMINE Y CHOI NURSE PRACTITIONER 40.00 0.00 X 127447 0 25705 1364759 0 211339 14 0 1 1 DAH CORPORATION DBA ISOUTSOURCE 19119 NORTH CREEK BOTHELL WA 98001 IT CONTRACTORS 433922 CLARK NUBER PS 10900 NE 4TH STREET BELLEVUE WA 98004 ACCOUNTING SERVICES 116205 2 86695 86695 PHARMACEUTICAL SALES 621400 119731067 119731067 CLINICAL RESEARCH SERV 621400 569391 569391 120300458 2094595 2094595 WORKSHOPS 900099 7049 7049 CREDIT CARD REBATE 900099 1833 1833 4 4 8886 122490634 120300458 0 2103481 849787 518571 331216 5996603 5202318 794285 317170 274326 42844 504572 359759 144813 348676 270601 78075 22465 22465 89086 89086 826974 578501 248473 372779 322898 49881 557661 470815 86846 1277041 1018299 258742 63683 53406 10277 20439 12716 7723 299932 184772 115160 419826 328593 91233 PHARMACY COSTS 95868352 95864047 4305 B&O TAXES 628057 628057 SPONSORSHIPS 100000 100000 FREIGHT 99860 99706 154 235404 222411 12993 108898367 106409796 2488571 0 7669005 6369846 35486304 37631847 13920578 14613287 1316213 4763046 140583 310637 3906365 886481 2973215 3019884 12762015 11965921 74267913 78674468 18603529 9950300 15299538 14696132 33833067 24646432 X 40434846 54028036 40434846 54028036 74267913 78674468 13592267 923 0 X 0 1 X 1 0 X 15272342 5082235 34125 64248 86695 20539645 8034782 99215222 53366090 113813074 120300458 394729626 23307124 104297457 53400215 113877322 120387153 415269271 0 650184 249354 5133375 7830509 13863422 650184 249354 5133375 7830509 13863422 401405849 5873 5282 603965 2094595 2709715 5873 5282 603965 2094595 2709715 8886 8886 23307124 104303330 53405497 114481287 122490634 417987872 0.96030 0.00650 X SCHEDULE A, PART III, LINE 12, EXPLANATION OF OTHER INCOME: WORKSHOPS - 2023 AMOUNT: $ 7,049. CREDIT CARD REBATE - 2023 AMOUNT: $ 1,833. MISCELLANEOUS - 2023 AMOUNT: $ 4. PART III THE ORGANIZATION FILED A SHORT-YEAR RETURN FOR TAX YEAR ENDED JUNE 30, 2022. AS A RESULT, THE FOLLOWING YEARS ON SCHEDULE A, PART III WERE ADJUSTED AS FOLLOWS. - TAX YEAR 2020: NUMBERS ARE NOW REPORTED IN THE 2019 TAX YEAR COLUMN. - TAX YEAR 2021: NUMBERS ARE NOW REPORTED IN THE 2020 TAX YEAR COLUMN. - TAX YEAR 2022: NUMBERS FOR THE SHORT-YEAR (01/01/22 - 06/30/22) ARE NOW REPORTED IN THE 2021 TAX YEAR COLUMN. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 3338113 606318 2731795 441920 218649 223271 126332 61514 64818 3019884 SECURITY DEPOSIT 462346 RIGHT OF USE ASSET 11503575 11965921 OPERATING LEASE LIABILITY 14696132 14696132 122491557 923 923 122490634 0 122490634 108898367 0 108898367 0 108898367 0 0 0 0 0 0 0 0 0 REBECCA KRUSE-JARRES MD EXECUTIVE/MEDICAL DIRECTOR 284614 0 0 0 0 0 0 0 66345 0 350959 0 0 0 KIM R SNYDER CHIEF FINANCIAL OFFICER/COO 245217 0 0 0 0 0 2942 0 10157 0 258316 0 0 0 HSIN KAI A CHEN PHARMACY DIRECTOR 164615 0 0 0 0 0 2444 0 20801 0 187860 0 0 0 HEEBEEN KIM CLINICAL PHARMACIST 145592 0 0 0 0 0 14924 0 10136 0 170652 0 0 0 CATLIN T GOODFRIEND CLINICAL PHARMACIST 134579 0 0 0 0 0 13823 0 10071 0 158473 0 0 0 ANNE JEZZAMINE Y CHOI NURSE PRACTITIONER 127447 0 0 0 0 0 13692 0 12013 0 153152 0 0 0 RENEE M KILLIAN CLINCIAL NURSE COORDINATOR 128294 0 0 0 0 0 13261 0 10143 0 151698 0 0 0 FORM 990, PART VII, SECTION A, LINE 5, UNRELATED ORGANIZATION COMPENSATION UNRELATED ORGANIZATION: UNIVERSITY OF WASHINGTON TYPE OF COMPENSATION PAID: SALARY AMOUNT OF COMPENSATION PAID: $350,959 PERSON RECEIVING COMPENSATION FROM UNRELATED ORGANIZATION: REBECCA KRUSE-JARRES, EXECUTIVE/MEDICAL DIRECTOR. FORM 990, PART I, LINE 6, VOLUNTEERS: THE WASHINGTON CENTER FOR BLEEDING DISORDERS (WACBD) HAD FOUR BOARD MEMBERS WHO EACH VOLUNTEERED APPROXIMATELY 12 HOURS OF SERVICE THROUGHOUT THE YEAR. FORM 990, PART VI, SECTION A, LINE 4 THE CHANGES ARE AS FOLLOWS: THE MAXIMUM NUMBER OF BOARD MEMBERS WILL INCREASE FROM 7 TO 9. EACH BOARD MEMBER, ASIDE FROM THE EXECUTIVE/MEDICAL DIRECTOR, WILL SERVE A 2-YEAR TERM AND CAN BE RE-ELECTED FOR UP TO FOUR CONSECUTIVE TERMS. THE EXECUTIVE DIRECTOR WILL HAVE A PERMANENT SEAT ON THE BOARD. A QUORUM WILL REQUIRE MORE THAN HALF OF THE BOARD MEMBERS TO BE PRESENT, WITH THE EXECUTIVE/MEDICAL DIRECTOR ALWAYS IN ATTENDANCE. FORM 990, PART VI, SECTION B, LINE 11B FORM 990 WAS PREPARED BY A PUBLIC ACCOUNTING FIRM, REVIEWED BY THE ORGANIZATION'S CFO/COO, AND PROVIDED TO THE BOARD. FORM 990, PART VI, SECTION B, LINE 12C ALL WASHINGTON CENTER FOR BLEEDING DISORDERS BOARD MEMBERS AND EMPLOYEES COMPLETE A CONFLICT-OF-INTEREST DISCLOSURE FORM ANNUALLY. IF ANY CONFLICT OF INTEREST OR APPEARANCE OF A CONFLICT OF INTEREST IS DISCLOSED, THIS WILL BE BROUGHT TO THE CONFLICT-OF-INTEREST COMMITTEE FOR REVIEW. FORM 990, PART VI, SECTION B, LINE 15B COMPENSATION FOR THE EXECUTIVE/MEDICAL DIRECTOR POSITION IS DETERMINED BY THE UNIVERSITY OF WASHINGTON, WHICH IS HER EMPLOYER. THE WASHINGTON INSTITUTE FOR COAGULATION HAS A SIGNED AGREEMENT WITH THE UNIVERSITY FOR ITS STAFF TO SERVE IN THIS EXECUTIVE/MEDICAL DIRECTOR ROLE. THIS AGREEMENT IS REVIEWED AND SIGNED ANNUALLY. THE SALARIES FOR OFFICERS AND KEY EMPLOYEES OF THE WASHINGTON INSTITUTE FOR COAGULATION ARE DETERMINED BASED ON COMPARISON TO SIMILAR POSITIONS WITHIN THE COMMUNITY AND AVERAGE RATES THAT ARE PAID. THIS WAS LAST PERFORMED IN LATE 2024 WHEN THE DIRECTOR OF FINANCE AND OPERATIONS WAS HIRED. FORM 990, PART VI, SECTION C, LINE 19 THE GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE PROVIDED UPON REQUEST.